Lataa...
Stimuli‐responsive delivery of therapeutics for diabetes treatment
Diabetic therapeutics, including insulin and glucagon‐like peptide 1 (GLP‐1), are essential for diabetic patients to regulate blood glucose levels. However, conventional treatments that are based on subcutaneous injections are often associated with poor glucose control and a lack of patient complian...
Tallennettuna:
| Julkaisussa: | Bioeng Transl Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5685194/ https://ncbi.nlm.nih.gov/pubmed/29147685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/btm2.10036 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|